Decreased HbA(1c) levels due to sulfonamide-induced hemolysis in two IDDM patients

Diabetes Care

Volumn 19, Issue 7, 1996, Pages 775-776

  Tack, Cees J J ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DAPSONE; FAMOTIDINE; FRUCTOSAMINE; HEMOGLOBIN A1C; INSULIN; PREDNISONE; SALAZOSULFAPYRIDINE; SULFONAMIDE; TRIMETHOPRIM; ANTIINFLAMMATORY AGENT; HEMOGLOBIN A;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; ERYTHROPOIESIS; FEMALE; HEMOLYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PNEUMOCYSTIS PNEUMONIA; RHEUMATOID ARTHRITIS; CHILD; DRUG EFFECT; METABOLISM;

ADULT; ANTI-INFLAMMATORY AGENTS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A; HEMOLYSIS; HUMANS; SULFASALAZINE;

EID: 0029658980     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.7.775     Document Type: Article

References (7)

1. Larsen ML, Hoører M, Mogensen EF: Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 323:1021-1025, 1990
2. Goldstein DE, Little RR, Lorenz, RA, Malone JI, Nathan D, Peterson CM: Technical review: test of glycemia in diabetes. Diabetes Care 18:896-909, 1995
3. 1. Diabetologia 27:596-598, 1984
4. Hoigné R, Malinverni R, Sonntag R: Sulfonamides, other folic acid antagonists and miscellaneous antibacterial drugs. In Meyler's Side Effects of Drugs. 12th ed. Dukes MNG, Ed. Amsterdam, Elsevier, 1992, p. 718-719
5. van Hees PAM, van Elferen LW, van Rossum JM, van Tongeren JHM: Hemolysis during salicylazosulfapyridine therapy. Am J Gastroenterol 70:501-505, 1979
6. DeGowin RL: A review of the therapeutic and hemolytic effects of dapsone. Arch Intern Med 120:242-248, 1967
7. Smart LM, Howie AF, Young RJ, Walker SW, Clarke BF, Smith AF: Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control. Diabetes Care 11:433-436, 1988